Pharmacological differences between beta-blockers and postoperative mortality following colon cancer surgery

β-blocker therapy has been positively associated with improved survival in patients undergoing oncologic colorectal resection. This study investigates if the type of β-blocker used affects 90-day postoperative mortality following colon cancer surgery. The study was designed as a nationwide retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Ekestubbe, Lovisa, Bass, Gary Alan, Forssten, Maximilian Peter, Sjölin, Gabriel, Cao, Yang, Matthiessen, Peter, Ahl Hulme, Rebecka, Mohseni, Shahin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960800/
https://www.ncbi.nlm.nih.gov/pubmed/35347168
http://dx.doi.org/10.1038/s41598-022-08736-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960800/
https://www.ncbi.nlm.nih.gov/pubmed/35347168
http://dx.doi.org/10.1038/s41598-022-08736-6

Ejemplares similares